Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Depreciation & Amortization - Total (2016 - 2017)

Nutex Health (NUTX) has disclosed Depreciation & Amortization - Total for 5 consecutive years, with $213.0 as the latest value for Q1 2017.

  • For Q1 2017, Depreciation & Amortization - Total rose 80.51% year-over-year to $213.0; the TTM value through Dec 2017 reached $213.0, down 54.97%, while the annual FY2016 figure was $473.0, 28.55% down from the prior year.
  • Depreciation & Amortization - Total hit $213.0 in Q1 2017 for Nutex Health, up from -$16723.0 in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $12505.0 in Q2 2016 and bottomed at -$16723.0 in Q4 2016.
  • Average Depreciation & Amortization - Total over 5 years is $534.0, with a median of $1191.0 recorded in 2014.
  • On a YoY basis, Depreciation & Amortization - Total climbed as much as 2671.52% in 2016 and fell as far as 10174.1% in 2016.
  • Nutex Health's Depreciation & Amortization - Total stood at $1673.0 in 2013, then decreased by 28.75% to $1192.0 in 2014, then crashed by 86.07% to $166.0 in 2015, then crashed by 10174.1% to -$16723.0 in 2016, then soared by 101.27% to $213.0 in 2017.
  • According to Business Quant data, Depreciation & Amortization - Total over the past three periods came in at $213.0, -$16723.0, and $4573.0 for Q1 2017, Q4 2016, and Q3 2016 respectively.